Manufactures specialty chemicals at four plants in India, with industrial chemicals contributing 87% of FY26 revenue and exports at 62% of revenue. Sells to over 2,000 customers across 21 Indian states and more than 50 countries, with end-use applications cited in data centers, solar, wind power, and turbine lubricants. FY26 revenue of ₹830 crores came on 33% volume growth, while plant capacity utilization was around 60-62% and EBITDA margin was 17.4%. A new R&D facility became fully operational in October 2025 to work on new molecules, and a 15-year supply contract was secured with a ₹51.4 crores advance received (rising to ₹98.12 crores by Q1 FY27), with revenue from this contract expected to start in FY28. Raw materials are the dominant cost at 59.9% of FY26 revenue. Management targets plant utilization above 75% in FY27 to lift EBITDA margin to around 20%, with FY27 capex guided at ₹125 crores (later raised to ₹250 crores in Q1 FY27). AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Industrial Chemicals (87%), Other chemicals (residual) (13%). Asset-heavy specialty chemicals manufacturer with high export exposure and capacity-utilisation-driven margin leverage.
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 613 | 672 | 594 | 668 | 830 |
| EBITDA (ex other income) | 93 | 115 | 100 | 110 | 143 |
| margin % | 15.2 | 17.1 | 16.8 | 16.4 | 17.2 |
| Owners' profit | 0 | 0 | 58 | 6 | 25 |
| EPS, as reported (₹) | 47.25 | 59.54 | 50.83 | 5.32 | 20.95 |
| ROE % · ROCE % | 30.2 · 34.2 | 28.5 · 25.8 | 19.7 · 12.9 | 1.5 · 8.8 | 5.7 · 11.3 |
| Debt / equity (x) | 1.03 | 1.36 | 1.86 | 1.33 | 1.22 |
| Cash from operations | 16 | 33 | 122 | (42) | 151 |
| Capex | (61) | (154) | (334) | (3) | (67) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 164 | 149 | 183 | 199 | 382 | 202 | 246 | 308 |
| Profit before tax | 5 | (2) | 8 | 6 | 12 | 6 | 17 | 49 |
| Net profit | 4 | (1) | 5 | 4 | 9 | 4 | 12 | 36 |
| EPS (₹) | 3.82 | (0.72) | 4.38 | 3.02 | 7.05 | 3.73 | 10.17 | 29.90 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| PIDILITE INDUSTRIES LTD | 1,59,479 | 60.2 | 14.43 | 42.3 | 22.4 | 28.0 | 14.9 | 28.6 |
| SRF LTD | 73,583 | 34.0 | 5.24 | 22.7 | 13.1 | 13.1 | 13.4 | 25.2 |
| GUJARAT FLUOROCHEM LTD | 52,514 | 85.7 | 6.64 | 41.5 | 7.3 | 8.7 | 13.5 | 27.7 |
| NAVIN FLUORINE INT. LTD | 43,836 | 55.4 | 11.03 | 39.5 | 16.7 | 16.4 | 23.0 | 37.5 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 10 Sept 2026 · Yasho Industries postal ballot notice published in newspapers | compliance | minimal | — | — |
| 9 Sept 2026 · Yasho Industries seeks shareholder nod to raise borrowing limit to Rs 1,250 Cr | board shareholder meetings | low | — | — |
| 3 Sept 2026 · Yasho Industries to hold investor group meeting on September 8 | board shareholder meetings | low | — | — |
| 27 Aug 2026 · Intimation of group meeting with analysts on September 1, 2026 | board shareholder meetings | low | — | — |
| 10 Aug 2026 · Transcript of investor call submitted to exchange | investor communications | medium | — | — |
| 10 Aug 2026 · Q1 FY27 earnings: revenue Rs 308 cr, EBITDA margin expands to 24% | investor communications | medium | — | — |
| 7 Aug 2026 · 40th AGM: All 8 resolutions passed, Rs 0.50 dividend declared | board shareholder meetings | medium | — | — |
| 6 Aug 2026 · Yasho Industries holds 40th AGM, 8 resolutions tabled including dividend | board shareholder meetings | low | — | — |
| 6 Aug 2026 · 40th AGM held on Aug 6, 2026; 8 resolutions including dividend | board shareholder meetings | medium | — | — |
| 3 Aug 2026 · Q1FY27 earnings call audio recording submitted to exchanges | investor communications | low | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) |
| AETHER INDUSTRIES LIMITED | 22,229 | 94.3 | 9.05 | 60.4 | 8.9 | 11.4 | — | 33.8 |
| DEEPAK NITRITE LTD | 21,769 | 27.8 | 3.71 | 22.4 | 9.4 | 10.2 | 12.6 | 21.5 |
| ATUL LTD | 18,401 | 23.1 | 2.92 | 14.9 | 10.9 | 13.3 | 10.9 | 23.1 |
| AARTI INDUSTRIES LTD | 17,846 | 33.6 | 3.00 | 18.8 | 7.0 | 4.4 | 13.0 | 16.2 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 83.0 | 23.4 | 93 of 103 | 10% |
| P/B | 11.5 | 2.9 | 93 of 99 | 6% |
| ROCE | 4.3 | 10.3 | 81 of 108 | 25% |
| ROE | 5.7 | 8.1 | 65 of 101 | 36% |
| Debt / Equity | 1.2 | 0.2 | 92 of 101 | 9% |
| EBITDA margin | 24.2 | 15.5 | 27 of 99 | 74% |
| Revenue growth | 54.9 | 24.4 | 14 of 94 | 86% |
| Profit growth | 889.2 | 55.1 | 5 of 92 | 96% |
| Market cap | 5088 | 732 | 24 of 107 | 78% |
| A state: the latest filed quarter and the measured reactions |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
